The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments

Author:

Hu WeihuanORCID,Xie Ningning,Zhu Hanyue,Jiang Yiting,Ding Sijia,Ye Shaoyan,Zhang Siwen,Wang Fangfang,Qu Fan,Zhou Jue

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference58 articles.

1. Polycystic ovary syndrome;Joham;Lancet Diabetes Endocrinol.,2022

2. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS);Moini Jazani;Daru,2019

3. Impact of Chinese herbal medicine on glucolipid metabolic outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis;Li;Evid. Based Complement Altern. Med.,2022

4. Chinese herbal medicine for the optimal management of polycystic ovary syndrome;Ong;Am. J. Chin. Med.,2017

5. Identification of the active constituents and significant pathways of cangfu daotan decoction for the treatment of PCOS based on network pharmacology;Xu;Evid. Based Complement Altern. Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3